logo
ProjectCompleted

Granules

The status, timeline and source of this project. A free account opens every field.

Source: International Finance Corporation (IFC)

Granules India Limited (Granules or the company) is a medium-sized generic pharmaceutical company based in Hyderabad, State of Andhra Pradesh, India. It is a leading manufacturer of pharmaceutical formulation intermediates (PFIs). PFIs are blends of single or multiple active pharmaceutical ingredients (APIs) and excipients, ready to be compressed into tablets or filled into capsules. Granules als

Status
Closed
Sector
Hospital, Manufacturing (Industrial), Government
Location
India
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Granules

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Granules” is an infrastructure initiative in the Hospital sector, located in India. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Granules India Limited (Granules or the company) is a medium-sized generic pharmaceutical company based in Hyderabad, State of Andhra Pradesh, India. It is a leading manufacturer of pharmaceutical formulation intermediates (PFIs). PFIs are blends of single or multiple active pharmaceutical ingredients (APIs) and excipients, ready to be compressed into tablets or filled into capsules. Granules also manufactures and sells APIs and formulations in over 35 countries globally. The company focuses mainly on a portfolio of high-volume drugs that have experienced post patent price erosions in the past (e.g. ibuprofen, paracetamol, aspirin, etc.). Granules has grown from one plant (Bonthapally) in 1987 to three (a new facility at the Bonthapally site plus plants at Gagilapur, and Jeedimetla, constructed in 2003 and 2006 respectively). A fourth plant is currently under construction at the 20-acre Gagilapur campus for the production of tablets; it is expected to be operational by June 2007. The company’s expansion plan is to leverage on its strength in low cost, large volume manufacturing and move up the industry value chain by expanding its product basket to include 8-10 new products each year, and manufacturing select, higher margin prescription drugs for the US and EU markets. To do so, Granules is in the process of setting up a new API and formulations facility and related product developments and registrations.

Original sector

FA - Pharmaceuticals and Medicine

Location

Country

India

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Hospital, Manufacturing (Industrial), Government

Article published date

2026-01-18

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project